DOM In the News
Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.
What's behind the FDA's controversial strategy for evaluating new COVID boosters
NPR |
Monica Gandhi was quoted by NPR commenting on antibody data regarding the BA.4/5 booster vaccines.
Should I get a fourth shot now, or wait for an Omicron-specific booster?
New York Times |
Peter Chin-Hong was mentioned in the New York Times explaining how the older you are, the more important it is to get a fourth Covid vaccine.
If I take Paxlovid for COVID, how does that affect my future immunity?
San Francisco Chronicle |
Bob Wachter was quoted in the San Francisco Chronicle explaining how Paxlovid affects future immunity to Covid.
How long does coronavirus stay in the air after someone with COVID leaves the room?
San Francisco Chronicle |
Peter Chin-Hong was featured in the San Francisco Chronicle discussing a study regarding how long Covid can linger in the air in a poorly ventilated space.
Biden covid case highlights confusing CDC guidance on ending isolation
Washington Post |
Bob Wachter explained to the Washington Post that people infected with Covid could still spread the virus, despite the CDC recommended five days of isolation.
How To Protect Yourself From The BA.5 Omicron Subvariant
NPR |
Bob Wachter was interviewed on NPR discussing the high rates of Covid and the federal government's vaccine strategy for the BA.4 and BA.5 variants.
COVID in California: Up to 10% of infected children at risk for long COVID
San Francisco Chronicle |
Bob Wachter was mentioned in the San Francisco Chronicle providing insight on President Biden’s recent Covid infection and treatment.
U.S. debates a summer booster for people under 50
NPR |
Bob Wachter was mentioned on NPR weighing in on how a second covid booster should be made available to all adults.
Will Bay Area counties follow L.A.’s footsteps and reintroduce a mask mandate?
San Francisco Chronicle |
Peter Chin-Hong was featured in the San Francisco Chronicle comparing current Covid infection reporting and the number of hospitalized patients to rates from earlier in the pandemic.
How Worried Should You Be About Omicron BA.5?
Washington Post |
Monica Gandhi was featured in the Washington Post regarding published studies looking into lasting immunity against the BA.5 Covid variant.
A new dominant omicron strain in the U.S. is driving up cases — and reinfections
NPR |
Bob Wachter was quoted on NPR explaining how prior infection of Covid does not provide effective immunity against the more infectious BA.5 variant.
What are the symptoms of an infection with BA.4 and BA.5?
New York Times |
Peter Chin-Hong was featured in the New York Times saying how those infected with the BA.4 and BA.5 Covid variants are less likely to experience shortness of breath or loss of taste or smell than with Delta or other variants.
Why UCSF’s Bob Wachter says COVID variant BA.5 is ‘a different beast’
San Francisco Chronicle |
Bob Wachter was featured in the San Francisco Chronicle explaining how the BA.5 strain of Covid is more infectious and more resistant to immune responses than the previous variants.
What to Know About the BA.2 Omicron Variant, the New Covid Strain
Wall Street Journal |
Peter Chin-Hong was quoted in the Wall Street Journal explaining why the BA.2 variant is called “stealth.”
Yes, some people will need a fourth shot. But most won’t.
Washington Post |
Monica Gandhi wrote an op-ed for the Washington Post weighing in on who will need a fourth dose of the Covid vaccine.